| Literature DB >> 36160030 |
Mizuki Nakaya1, Miho Wakamatsu1, Hinaki Motegi1, Ami Tanaka1, Kenneth Sutherland2, Masayori Ishikawa3, Michitaka Ozaki4, Hiroki Shirato2, Kazuko Hamada1, Toshiyuki Hamada1,4,5.
Abstract
Clock gene expression in most organs of the living body exhibits a diurnal rhythm synchronized with the external 24 h light-dark (LD) cycle via circadian pacemaker suprachiasmatic nucleus (SCN). Disturbances in clock gene expression due to desynchronization of clock gene expression of the external LD cycle are risk factors for developing various diseases. Measuring the in vivo clock genes expression rhythm for a long duration under LD conditions can greatly contribute to understand the pathogenic mechanism of the disease caused by the disturbance of the biological rhythm. However, it is presently difficult to continuously measure gene expression for a long duration under LD conditions. In present study, we succeeded in measuring Period1 (Per1) gene expression under LD conditions using ultraviolet (UV) light with filter cut the visible light range. In addition, we succeeded in measuring the kinetic change of liver Per1 gene expression during the process of desynchronization of behavioral rhythm from the LD cycle by chronic administration of methamphetamine (MAP). In the future, by using this system to measure clock gene expression rhythms of brain tissues such as SCN and peripheral tissues under LD conditions, it could contribute to understand the onset mechanism of diseases induced by the desynchronization mechanism of biological rhythm to the LD cycle.Entities:
Keywords: Circadian rhythm; In vivo; Luciferin; Methamphetamine; Period1
Year: 2022 PMID: 36160030 PMCID: PMC9489493 DOI: 10.1016/j.bbrep.2022.101344
Source DB: PubMed Journal: Biochem Biophys Rep ISSN: 2405-5808
Fig. 1Locomotor activity rhythm and Per1 gene expression of Per1-luc mice in UV LD conditions.
(A). Locomotor activity rhythm under UV 12/12 light-dark conditions. Spontaneous locomotor activity records are expressed in black histograms of activity counts in 5 min bin and double-plotted so that 48 h are shown on the x-axis and consecutive days on the y-axis. (B). The effect of UV light on behavior rhythm in subjective day and night. Grey squares show the time zone when the UV light pulse was exposed (CT13-16 or CT8-11). Red lines show the regression lines fitted to the onset of activity time before and after UV light exposure. (C). The effect of UV light on locomotor activity rhythm by 3h UV light exposure in DD conditions. Each column indicates the mean ± SD (n = 3). Statistical significance was detected by Student’ t-test (***P < 0.05 vs. CT8∼11). (D, E).Per1 expression rhythm in the liver of Per1-luc mouse in UV LD conditions (D) and DD conditions (E). Luminescence (red curve) was computed by subtracting the 24 h moving average from the original data. (For interpretation of the references to colour in this figure legend, the reader is referred to the Web version of this article.)
Fig. 2Chronic methamphetamine administration affects the period of locomotor activity in UV LD conditions.
(A–D). Chronic MAP induced locomotor activity rhythm in UV LD conditions. Day 0 indicates the start day of MAP administration (0.005%). Each periodogram corresponds to a∼f in actograms. MAP was withdrawn at the time of triangle arrow in f (MAP-containing water bottle was replaced with the bottle containing pure water). Per1 expressions in the SCN were examined at * (ZT5) using LUC antibody in Fig. 2A. The period of locomotor activity rhythms are shown in a∼f. Per1 gene expression rhythms from ①∼⑩ in actogram in Fig. 2C are shown in Supplementary Figure S2. (E).Per1 expression in the SCN at ZT5 (* in Fig. 2A). Third ventricle (3V); optic chasm (OC); suprachiasmatic nucleus (SCN). (F). Day-night difference of Per1 expression in the SCN. Data are mean ± SDM (n = 3). Statistical significance as detected by student's t-test (***P < 0.001). The scale bar is 200 μm.
Fig. 3Kinetic-Per1 expression change in the liver of a freely moving mouse in UV LD conditions.
Chronic MAP induced locomotor activity and Per1 gene expression rhythms in UV LD conditions. The black triangle indicates the start day of MAP administration (0.005%). Per1 gene expression rhythms were measured at ①∼⑫ in actogram. The two headed arrows and numbers at the top of the figure ①∼⑫ indicate the period of Per1 gene expression rhythm. The two headed dotted arrows in the figure ⑧ indicate the duration of no luciferin application. The periodograms from a∼e are shown in Supplementary Figure S3.
Fig. 4Relationship between Per1 gene expression and behavior activity under chronic methamphetamine administration.
(A). The period of Per1 gene expression in the liver and behavior activity rhythms in UV LD conditions. ①∼⑫ in the horizontal axis correspond to that of Fig. 3.
“-” indicates no MAP treatment. “+” indicates 0.005% MAP treatment. The slit peak (two peaks) of Per1 gene expression rhythm is shown with “#”. The mean periods of behavior activity and Per1 expression rhythms in UV LD cycle without MAP are shown as horizontal grey lines at 24.0 h “*” indicates the split of onset and offset of daily activity. The black dotted line suggests that the period of behavioral activity rhythms is unstable. (B). The amount of water intake under chronic MAP administration. (C). The period changes of Per1expression before and after methamphetamine treatment in individual mice. Data are mean ± SD. (D). The period changes of locomotor activity rhythm on the same mouse measured Per1 expression rhythm in Fig. 4C. (E, F). Effect of MAP on the period of Per1 expression rhythm in the liver and locomotor activity rhythm at each stage. Pre, MAP a, Map b and Map c in the horizontal axis correspond to that of Fig. 4A (n = 4 animals). Statistical significance as determined by one-way ANOVA followed by Dunnett's test (*P < 0.05 **P < 0.01 vs pre). (G). Effect of MAP on the drinking activity at each stage (n = 4 animals).